Tandem Diabetes Care (TNDM) Change in Acquisitions & Divestments (2014 - 2026)

Tandem Diabetes Care has reported Change in Acquisitions & Divestments for 13 years, with the latest figure at $27.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 58.58% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $219.0 million (down 23.94% YoY), and the FY2025 full-year result was $257.1 million, down 16.12% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $27.0 million, down from $56.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $166.4 million in Q3 2022, with the low at $27.0 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $100.4 million across 5 years, with a median of $96.4 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments soared 928.27% — and 2026, when it sank 58.58%.
• Tandem Diabetes Care's Change in Acquisitions & Divestments stood at $146.6 million in 2022, then fell by 10.81% to $130.7 million in 2023, then plunged by 48.42% to $67.4 million in 2024, then dropped by 16.23% to $56.5 million in 2025, then tumbled by 52.29% to $27.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $27.0 million (Q1 2026), $56.5 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.